SlideShare une entreprise Scribd logo
1  sur  1
Télécharger pour lire hors ligne
COMMUNIQUE DE PRESSE
NOUVEAUX LAUREATS Réseau Entreprendre® Bretagne en Ille et Vilaine
L’accompagnement Réseau Entreprendre Bretagne, gage de succès pour les créateurs
et repreneurs de PME
2 juin 2016 – Nathalie MAUBON et Julian BURSZTYKA deviennent Lauréats de Réseau Entreprendre®
Bretagne pour l’entreprise HCS PHARMA crée en aout 2014. Ils bénéficient d’un prêt d’honneur de
40 000 euros et seront accompagnés par Laurent Bernadac, Membre de Réseau Entreprendre®
Bretagne.
Nathalie Maubon et Julian Bursztyka démarrent HCS Pharma en août 2014 sous la forme d’une SAS.
HCS Pharma est une société qui vise à développer des modèles biologiques in vitro innovants,
miniaturisés, et automatisés, utilisables en HCS. Ces modèles biologiques sont destinés à être proposés
aux industries pharmaceutiques et entreprises de biotechnologies afin de tester l’efficacité et/ou la non
toxicité de leurs molécules, par le biais de services réalisés par HCS Pharma au sein de ses locaux au
Biopôle.
Réseau Entreprendre® Bretagne accompagne, depuis 2003, les créateurs et repreneurs bretons de PME à
potentiel de développement et créatrices d’emplois. Association reconnue d’utilité publique, elle fédère plus
de 300 dirigeants bretons de PME, bénévoles, qui accompagnent gratuitement les créateurs et repreneurs de
PME à potentiel sur tout le territoire breton. A ce jour, ce sont 300 entreprises lauréates qui ont bénéficié de
l’Accompagnement individuel et collectif et de l’aide au financement sous forme de Prêt d’honneur de Réseau
Entreprendre® Bretagne. Par ailleurs, Réseau Entreprendre® Bretagne gère le fonds d’amorçage régional
PHAR.
Quelques chiffres sur Réseau Entreprendre® Bretagne
C’est plus de 300 chefs d’entreprises qui adhèrent et participent à l’action menée,
7.5 M€ de prêts d’honneur engagés pour nos lauréats depuis 2003,
Plus de 300 entreprises lauréates depuis l’origine représentant 5000 emplois.
Réseau Entreprendre® Bretagne, Qui mieux qu’un chef d’entreprise peut accompagner un nouvel
entrepreneur ?
Contacts :
Philippe Edelmayer
Délégué Ille et Vilaine
Réseau Entreprendre® Bretagne
2 allée du Bâtiment
BP 71657
35016 RENNES CEDEX
02 99 36 22 76 - bretagne@reseau-entreprendre.org
Plus d’informations sur www.reseau-entreprendre-
bretagne.fr
Nathalie MAUBON
Julian BURSZTYKA
6 rue Pierre Joseph Colin
35000 Rennes
06 61 87 14 38
Nathalie.maubon@hcs-pharma.com

Contenu connexe

En vedette

Agri-tech D.PARTY - 유비엔 (UBN) 스마트팜 - 160421 @ D.CAMP
Agri-tech D.PARTY - 유비엔 (UBN) 스마트팜 - 160421 @ D.CAMPAgri-tech D.PARTY - 유비엔 (UBN) 스마트팜 - 160421 @ D.CAMP
Agri-tech D.PARTY - 유비엔 (UBN) 스마트팜 - 160421 @ D.CAMPD.CAMP
 
[중소기업청]두꺼비세상 소개서
[중소기업청]두꺼비세상 소개서[중소기업청]두꺼비세상 소개서
[중소기업청]두꺼비세상 소개서startupkorea
 
10 Scary HR Stats That'll Make You Howl This Halloween
10 Scary HR Stats That'll Make You Howl This Halloween10 Scary HR Stats That'll Make You Howl This Halloween
10 Scary HR Stats That'll Make You Howl This HalloweenAchievers
 
SK플래닛 M&C부문 D-spark #1 Intro & New Digital
 SK플래닛 M&C부문 D-spark #1 Intro & New Digital SK플래닛 M&C부문 D-spark #1 Intro & New Digital
SK플래닛 M&C부문 D-spark #1 Intro & New DigitalD:rink
 
빅데이터의 개념과 이해 그리고 활용사례 (Introduction to big data and use cases)
빅데이터의 개념과 이해 그리고 활용사례 (Introduction to big data and use cases)빅데이터의 개념과 이해 그리고 활용사례 (Introduction to big data and use cases)
빅데이터의 개념과 이해 그리고 활용사례 (Introduction to big data and use cases)Wonjin Lee
 
SMAC Portfolio
SMAC PortfolioSMAC Portfolio
SMAC PortfolioNeobric
 

En vedette (7)

Agri-tech D.PARTY - 유비엔 (UBN) 스마트팜 - 160421 @ D.CAMP
Agri-tech D.PARTY - 유비엔 (UBN) 스마트팜 - 160421 @ D.CAMPAgri-tech D.PARTY - 유비엔 (UBN) 스마트팜 - 160421 @ D.CAMP
Agri-tech D.PARTY - 유비엔 (UBN) 스마트팜 - 160421 @ D.CAMP
 
[중소기업청]두꺼비세상 소개서
[중소기업청]두꺼비세상 소개서[중소기업청]두꺼비세상 소개서
[중소기업청]두꺼비세상 소개서
 
10 Scary HR Stats That'll Make You Howl This Halloween
10 Scary HR Stats That'll Make You Howl This Halloween10 Scary HR Stats That'll Make You Howl This Halloween
10 Scary HR Stats That'll Make You Howl This Halloween
 
SK플래닛 M&C부문 D-spark #1 Intro & New Digital
 SK플래닛 M&C부문 D-spark #1 Intro & New Digital SK플래닛 M&C부문 D-spark #1 Intro & New Digital
SK플래닛 M&C부문 D-spark #1 Intro & New Digital
 
빅데이터의 개념과 이해 그리고 활용사례 (Introduction to big data and use cases)
빅데이터의 개념과 이해 그리고 활용사례 (Introduction to big data and use cases)빅데이터의 개념과 이해 그리고 활용사례 (Introduction to big data and use cases)
빅데이터의 개념과 이해 그리고 활용사례 (Introduction to big data and use cases)
 
Investment Funds Regime in Guernsey 21 July 2016
Investment Funds Regime in Guernsey 21 July 2016Investment Funds Regime in Guernsey 21 July 2016
Investment Funds Regime in Guernsey 21 July 2016
 
SMAC Portfolio
SMAC PortfolioSMAC Portfolio
SMAC Portfolio
 

Plus de HCS Pharma

Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...HCS Pharma
 
Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...HCS Pharma
 
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...HCS Pharma
 
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...HCS Pharma
 
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCS Pharma
 
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...HCS Pharma
 
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...HCS Pharma
 
BIOMIMESYS® Liver
BIOMIMESYS® LiverBIOMIMESYS® Liver
BIOMIMESYS® LiverHCS Pharma
 
BIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissueBIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissueHCS Pharma
 
BIOMIMESYS® Oncology
BIOMIMESYS® OncologyBIOMIMESYS® Oncology
BIOMIMESYS® OncologyHCS Pharma
 
Importance of matricial and cellular microenvironments in in vitro models for...
Importance of matricial and cellular microenvironments in in vitro models for...Importance of matricial and cellular microenvironments in in vitro models for...
Importance of matricial and cellular microenvironments in in vitro models for...HCS Pharma
 
Simplifying 3d cell culture generation for high content screening with BIOMIM...
Simplifying 3d cell culture generation for high content screening with BIOMIM...Simplifying 3d cell culture generation for high content screening with BIOMIM...
Simplifying 3d cell culture generation for high content screening with BIOMIM...HCS Pharma
 
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...HCS Pharma
 
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...HCS Pharma
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...HCS Pharma
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development	and	automation of 3D innovative	hiPSC-based liver organo...Poster – Development	and	automation of 3D innovative	hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...HCS Pharma
 
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...HCS Pharma
 
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...HCS Pharma
 
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® BrainHCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® BrainHCS Pharma
 
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldA groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldHCS Pharma
 

Plus de HCS Pharma (20)

Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
Poster HCSPHARMA (OncoLilleDays2022) - Mechanobiological characterization of ...
 
Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...Poster : Development of personalized therapeutic targeting in lung cancer wit...
Poster : Development of personalized therapeutic targeting in lung cancer wit...
 
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
Poster - Including the matricial tumoral microenvironment in 3D in vitro mode...
 
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
HCS PHARMA - (ECM 2022) Development of innovative hiPSC-based model including...
 
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
HCSPHARMA Importance of microenvironment in cerebral in vitro models for phen...
 
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...Poster - A single procedure to generate functional hiPSCs-derived liver organ...
Poster - A single procedure to generate functional hiPSCs-derived liver organ...
 
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
Poster - BIOMIMESYS® 3D hydroscaffold a matricial microenvironment for physio...
 
BIOMIMESYS® Liver
BIOMIMESYS® LiverBIOMIMESYS® Liver
BIOMIMESYS® Liver
 
BIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissueBIOMIMESYS® Adipose tissue
BIOMIMESYS® Adipose tissue
 
BIOMIMESYS® Oncology
BIOMIMESYS® OncologyBIOMIMESYS® Oncology
BIOMIMESYS® Oncology
 
Importance of matricial and cellular microenvironments in in vitro models for...
Importance of matricial and cellular microenvironments in in vitro models for...Importance of matricial and cellular microenvironments in in vitro models for...
Importance of matricial and cellular microenvironments in in vitro models for...
 
Simplifying 3d cell culture generation for high content screening with BIOMIM...
Simplifying 3d cell culture generation for high content screening with BIOMIM...Simplifying 3d cell culture generation for high content screening with BIOMIM...
Simplifying 3d cell culture generation for high content screening with BIOMIM...
 
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
BIOMIMESYS®Liver, a 3D cell culture model for maintaining and promoting hepat...
 
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...Abstract : a single procedure to generate functional hi ps cs-derived liver o...
Abstract : a single procedure to generate functional hi ps cs-derived liver o...
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
 
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
Poster – Development	and	automation of 3D innovative	hiPSC-based liver organo...Poster – Development	and	automation of 3D innovative	hiPSC-based liver organo...
Poster – Development and automation of 3D innovative hiPSC-based liver organo...
 
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
Development of a new liver-on-chip including BIOMIMESYS® technology for mimic...
 
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
HCS Pharma complète sa gamme de culture cellulaire en 3D BIOMIMESYS® avec BIO...
 
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® BrainHCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
HCS Pharma extends its 3D cell culture range BIOMIMESYS® with BIOMIMESYS® Brain
 
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffoldA groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
A groundbreaking 3D cell culture technology for HCS: BIOMIMESYS hydroscaffold
 

HCS Pharma lauréat de Réseau Entreprendre® Bretagne

  • 1. COMMUNIQUE DE PRESSE NOUVEAUX LAUREATS Réseau Entreprendre® Bretagne en Ille et Vilaine L’accompagnement Réseau Entreprendre Bretagne, gage de succès pour les créateurs et repreneurs de PME 2 juin 2016 – Nathalie MAUBON et Julian BURSZTYKA deviennent Lauréats de Réseau Entreprendre® Bretagne pour l’entreprise HCS PHARMA crée en aout 2014. Ils bénéficient d’un prêt d’honneur de 40 000 euros et seront accompagnés par Laurent Bernadac, Membre de Réseau Entreprendre® Bretagne. Nathalie Maubon et Julian Bursztyka démarrent HCS Pharma en août 2014 sous la forme d’une SAS. HCS Pharma est une société qui vise à développer des modèles biologiques in vitro innovants, miniaturisés, et automatisés, utilisables en HCS. Ces modèles biologiques sont destinés à être proposés aux industries pharmaceutiques et entreprises de biotechnologies afin de tester l’efficacité et/ou la non toxicité de leurs molécules, par le biais de services réalisés par HCS Pharma au sein de ses locaux au Biopôle. Réseau Entreprendre® Bretagne accompagne, depuis 2003, les créateurs et repreneurs bretons de PME à potentiel de développement et créatrices d’emplois. Association reconnue d’utilité publique, elle fédère plus de 300 dirigeants bretons de PME, bénévoles, qui accompagnent gratuitement les créateurs et repreneurs de PME à potentiel sur tout le territoire breton. A ce jour, ce sont 300 entreprises lauréates qui ont bénéficié de l’Accompagnement individuel et collectif et de l’aide au financement sous forme de Prêt d’honneur de Réseau Entreprendre® Bretagne. Par ailleurs, Réseau Entreprendre® Bretagne gère le fonds d’amorçage régional PHAR. Quelques chiffres sur Réseau Entreprendre® Bretagne C’est plus de 300 chefs d’entreprises qui adhèrent et participent à l’action menée, 7.5 M€ de prêts d’honneur engagés pour nos lauréats depuis 2003, Plus de 300 entreprises lauréates depuis l’origine représentant 5000 emplois. Réseau Entreprendre® Bretagne, Qui mieux qu’un chef d’entreprise peut accompagner un nouvel entrepreneur ? Contacts : Philippe Edelmayer Délégué Ille et Vilaine Réseau Entreprendre® Bretagne 2 allée du Bâtiment BP 71657 35016 RENNES CEDEX 02 99 36 22 76 - bretagne@reseau-entreprendre.org Plus d’informations sur www.reseau-entreprendre- bretagne.fr Nathalie MAUBON Julian BURSZTYKA 6 rue Pierre Joseph Colin 35000 Rennes 06 61 87 14 38 Nathalie.maubon@hcs-pharma.com